6 hours Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue EstimatesZacks
Century Therapeutics (IPSC) delivered earnings and revenue surprises of 19.57% and 69.74%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X